Interspecies Brain PBPK Modeling Platform to Predict Passive Transport through the Blood–Brain Barrier and Assess Target Site Disposition
The high failure rate of central nervous system (CNS) drugs is partly associated with an insufficient understanding of target site exposure. Blood–brain barrier (BBB) permeability evaluation tools are needed to explore drugs’ ability to access the CNS. An outstanding aspect of physiologically based...
Main Authors: | Parsshava Mehta, Amira Soliman, Leyanis Rodriguez-Vera, Stephan Schmidt, Paula Muniz, Monica Rodriguez, Marta Forcadell, Emili Gonzalez-Perez, Valvanera Vozmediano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/16/2/226 |
Similar Items
-
A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis
by: Federico Reali, et al.
Published: (2024-01-01) -
Physiologically Based Pharmacokinetics Model in Pregnancy: A Regulatory Perspective on Model Evaluation
by: Paola Coppola, et al.
Published: (2021-06-01) -
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics
by: Keyur R. Parmar, et al.
Published: (2023-06-01) -
A computational investigation of the ventilation structure and maximum rate of metabolism for a physiologically based pharmacokinetic (PBPK) model of inhaled xylene
by: Karen A Yokley, et al.
Published: (2019-02-01) -
Blood-Nanoparticle Interactions Create a Brain Delivery Superhighway for Doxorubicin
by: Li Z, et al.
Published: (2024-03-01)